However, paralemmin-2 was equally expressed in both recurrent and nonrecurrent non-small cell lung carcinomas and it was not determined whether paralemmin-2 levels were higher in tumors than in normal tissue. Here, PALM2AKAP2 is linked to non-small cell lung carcinoma.